poisar

Stocks · News reference

Morgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13

Benzinga Newsdesk

Morgan Stanley analyst Maxwell Skor initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Overweight rating and announces Price Target of $13.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ACHV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K filing — ACHIEVE LIFE SCIENCES, INC. (ACHV)

    Filed: 2026-10-01 AccNo: 0001193125-26-410781 Size: 209 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    ACHV